Form D · Private Equity Fund

Blackstone Life Sciences V Access Fund, L.P.

New York, NY · CIK 0001817675

Offering snapshot reported Sep 18, 2020 · SEC filing

Reported sold: $384M
Investors reported: 1,883
Minimum accepted: $100K
First sale: Jul 6, 2020

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$0 → $383,868,991

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Sep 18, 2020	Amendment	$383,868,991	$383,868,991vs Jul 10, 2020	1,883	SEC filing
Jul 10, 2020	Initial	$0	No comparison	1,883	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: No
Business combination: No

Sales commissions: $2.76M
Finders' fees: $0
Form D file number: 021-370747

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Merrill Lynch, Pierce, Fenner & Smith Incorporated	7691

Source: Form D, filed Sep 18, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
N/A N/A Asterion Fund Services L.L.C.	Promoter
Scott Huff	Executive
N/A N/A I Capital Alternative Investments Llc	Executive
Barbra E Kocsis	Executive
N/A N/A Maples Fiduciary Services (Delaware) Inc.	Executive
Edward L. Truitt, Jr.	Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

One Grand Central Place 60 East 42 Nd Street, 26 Th Floor
New York, NY, 10165